unknown
Stage
About
Vortex Biosciences develops and sells the VTX-1 benchtop liquid biopsy system that isolates intact circulating tumour cells (CTCs) from whole blood using size- and deformability-based microscale vortices. The company supplies the automated instrument and recurring disposable cartridges for CTC capture and enrichment for research and clinical applications.
Explore Vortex Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.